SOX2 and esophageal squamous cell carcinoma: Next, we used various doses of Verteporfin to treat ESCC cells for 72 h and found that the protein status of stemness-related molecules involving ABCG2, SOX2 and NANOG presented a downward trend following the increasing Verteporfin concentrations (Fig. 3j, k).